疫苗前沿 | 突破mRNA应用的局限，这一技术能带来新一代疗法吗？

 

 

 

 

参考资料：

[1] ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience. Retrieved September 8, 2021, from https://www.prnewswire.com/news-releases/atp-announces-40-million-in-series-a-funding-for-srrna-therapeutics-trailblazer-replicate-bioscience-301370789.html

[2] Spurred on by Moderna and Pfizer's success, a Belgian biotech has big ambitions for its self-amplifying RNA vaccine play. Retrieved September 8, 2021, from https://endpts.com/spurred-on-by-moderna-and-pfizers-success-a-belgian-biotech-has-big-ambitions-for-its-self-amplifying-rna-vaccine-play/

[3] Bloom et al., (2020). Self-amplifying RNA vaccines for infectious diseases. Gene Therapy, https://doi.org/10.1038/s41434-020-00204-y

打赏